Teitl: A cohort study to establish the prevalence of mutations in patients with CML who meet the ELN criteria for warning or failure and patients with Ph+ALL with detectable BCR-ABL1 currently being treated with first or subsequent TKI therapy in the UK

Arianwyr
Cardiff & Vale University Health Board

Prif Ymchwiliwr

Manylion y Prosiect
Gwerth net y ffigur a ddyfarnwyd i Brifysgol Caerdydd: £3,263.00
Dyddiad dechrau: 06.12.2019
Dyddiad gorffen: 30.06.2020

Diweddarwyd y tro diwethaf ar 2019-08-12 am 06:01